Basel Medical Group Ltd Ordinary Shares (BMGL) Stock Overview
Explore Basel Medical Group Ltd Ordinary Shares’s financial performance, market position, analyst ratings, and future outlook.
Basel Medical Group Ltd Ordinary Shares (BMGL)
Key Financials
Key Financials
Market Cap
9.2M
P/E Ratio
-20.69
EPS (TTM)
$-5.29
ROE
-1.74%
BMGL Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Basel Medical Group Ltd Ordinary Shares (NASDAQ: BMGL) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Basel Medical Group Ltd Ordinary Shares's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of BMGL on the NASDAQ shows an RSI of 54.20, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.
Key metrics behind Basel Medical Group Ltd Ordinary Shares's NASDAQ-traded stock include a P/E ratio of -20.69 and a market capitalization of 9.2M. Combined with our AI analysis, these give both institutional and retail investors a clear view of BMGL on the NASDAQ.